By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Opioid analgesic > Morphine

Morphine

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|627 words

Morphine Drug Profile

What is Morphine?

Morphine is a powerful opioid analgesic medication derived from the opium poppy plant. It belongs to the class of drugs known as narcotic pain relievers or opioid analgesics. Morphine is primarily used to treat moderate to severe pain, particularly in hospital settings, cancer care, and end-of-life care where strong pain relief is essential.

Uses

Morphine is approved for several medical conditions requiring significant pain management:

  • Severe acute pain: Used in emergency departments and hospitals for trauma, post-surgical pain, and severe injuries
  • Cancer pain: Provides relief for moderate to severe pain associated with cancer and cancer treatments
  • Chronic pain management: Used when other pain medications have proven inadequate for long-term pain conditions
  • Myocardial infarction pain: Administered to relieve chest pain during heart attacks
  • Palliative care: Essential for comfort care in terminally ill patients to improve quality of life

How it works

Morphine works by binding to specific opioid receptors in the brain, spinal cord, and other parts of the nervous system. These receptors, primarily mu-opioid receptors, normally respond to the body’s natural pain-relieving chemicals. When morphine attaches to these receptors, it blocks pain signals from reaching the brain and releases chemicals that create feelings of pain relief and, in some cases, euphoria.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and sedation
  • Nausea and vomiting
  • Constipation
  • Dizziness or lightheadedness
  • Dry mouth
  • Confusion or mental cloudiness
  • Sweating
  • Loss of appetite

Serious side effects that require immediate medical attention:

  • Respiratory depression (slow or difficult breathing)
  • Severe allergic reactions with swelling or rash
  • Signs of overdose including extreme drowsiness or unconsciousness
  • Chest pain or irregular heartbeat
  • Severe abdominal pain or intestinal blockage

Warnings and precautions

  • Addiction and dependence risk: Morphine has high potential for physical dependence, tolerance, and addiction, requiring careful monitoring and gradual discontinuation
  • Respiratory conditions: Should be avoided or used with extreme caution in patients with asthma, COPD, or other breathing disorders due to risk of respiratory depression
  • Pregnancy considerations: Classified as pregnancy category C; use only when benefits outweigh risks, as it can cause withdrawal symptoms in newborns
  • Kidney and liver impairment: Dosage adjustments necessary in patients with reduced kidney or liver function, as the drug clearance may be significantly delayed
  • Age-related concerns: Elderly patients are more sensitive to morphine’s effects and may require lower doses and more frequent monitoring

Interactions

  • CNS depressants: Alcohol, benzodiazepines, and sleep medications can increase sedation and respiratory depression risk
  • MAO inhibitors: Can cause dangerous increases in morphine’s effects and should be avoided within 14 days of MAO inhibitor use
  • Muscle relaxants: May enhance respiratory depression and sedation when combined with morphine
  • Antihistamines: Can increase drowsiness and confusion, particularly in elderly patients
  • Rifampin: May reduce morphine’s effectiveness by increasing its metabolism in the liver
  • Cimetidine: Can increase morphine blood levels by inhibiting its breakdown
  • St. John’s Wort: May decrease morphine’s effectiveness by inducing liver enzymes that break down the drug
  • Grapefruit juice: May alter absorption and increase side effects in some formulations

Check interactions with the GMJ Interaction Checker

Dosage

Morphine dosing is highly individualized and must be determined by a healthcare provider based on the patient’s pain severity, previous opioid exposure, and medical condition. Typical adult starting doses for immediate-release oral morphine range from 10-30 mg every 4 hours for opioid-naive patients. Extended-release formulations may start at 15-30 mg every 8-12 hours. Injectable forms are typically dosed lower due to increased bioavailability. Dosage adjustments are made gradually based on pain relief and tolerability. Patients should never adjust their own dosing, and morphine should always be taken exactly as prescribed by a healthcare provider.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Morphine." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/morphine/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Regional Nerve Block Reduces Opioid Use After Heart Surgery by 25%, Multicentre Trial Shows The Chemical Language of the Brain: How Neurotransmitter Balance Shapes Mental Health
In the news
  • Regional Nerve Block Reduces Opioid Use After Heart Surgery by 25%, Multicentre Trial Shows · May 29, 2026
  • The Chemical Language of the Brain: How Neurotransmitter Balance Shapes Mental Health · May 21, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Five Flavanol-Rich Foods Can Significantly Reduce Heart Disease Risk, New Study Finds

New research identifies five specific flavanol-rich foods that provide superior cardiovascular protection…

American Horses Mirror Human Obesity Crisis, Revealing Shared Environmental Risk Factors

American horses are developing obesity and metabolic syndrome at unprecedented rates, mirroring…

Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial

Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Hydromorphone

By
Prof. Giorgi Pkhakadze
02/06/2026

Tramadol

By
Prof. Giorgi Pkhakadze
02/06/2026

Fentanyl

By
Prof. Giorgi Pkhakadze
02/06/2026

Meperidine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up